# Bleeding Pattern Study

> **NCT00302666** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 1315 (actual)

## Conditions studied

- Oral Contraceptive

## Interventions

- **DRUG:** Valette (Dienogest/EE30, BAY86-5038)
- **DRUG:** Valette (Dienogest/EE30, BAY86-5038)

## Key facts

- **NCT ID:** NCT00302666
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 1315 (ACTUAL)
- **Last updated:** 2009-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302666, "Bleeding Pattern Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00302666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*